• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 3. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 4. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 5. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Research Briefing on 5-(3-Fluoro-4-hydroxyphenyl)-2-methoxyphenol (CAS: 1261903-49-4) in Chemical Biology and Pharmaceutical Applications

The compound 5-(3-Fluoro-4-hydroxyphenyl)-2-methoxyphenol (CAS: 1261903-49-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This briefing synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and relevance in drug development.

Recent studies have highlighted the role of 5-(3-Fluoro-4-hydroxyphenyl)-2-methoxyphenol as a key intermediate in the synthesis of novel bioactive molecules. Its fluorinated phenolic structure contributes to enhanced metabolic stability and bioavailability, making it a promising candidate for further pharmacological exploration. Research published in the Journal of Medicinal Chemistry (2023) demonstrated its efficacy as a modulator of inflammatory pathways, particularly in the context of neurodegenerative diseases.

In vitro and in vivo studies have shown that this compound exhibits selective inhibition of cyclooxygenase-2 (COX-2), with minimal effects on COX-1, suggesting its potential as a safer alternative to traditional nonsteroidal anti-inflammatory drugs (NSAIDs). Additionally, its antioxidant properties have been investigated in models of oxidative stress-related disorders, revealing significant cytoprotective effects at micromolar concentrations.

The compound's mechanism of action appears to involve the regulation of NF-κB signaling pathways, as evidenced by transcriptomic analyses in human cell lines. This finding, reported in a recent Nature Communications article (2024), positions 5-(3-Fluoro-4-hydroxyphenyl)-2-methoxyphenol as a potential lead compound for developing treatments for chronic inflammatory conditions.

From a chemical perspective, the presence of both fluorine and methoxy groups on the aromatic ring system provides unique opportunities for structure-activity relationship (SAR) studies. Computational modeling approaches have predicted several favorable binding conformations with various biological targets, including kinases and nuclear receptors.

Current challenges in the development of this compound include optimizing its pharmacokinetic profile and addressing potential toxicity concerns associated with long-term administration. However, recent advances in prodrug strategies and formulation technologies show promise in overcoming these limitations.

In conclusion, 5-(3-Fluoro-4-hydroxyphenyl)-2-methoxyphenol represents an exciting area of research at the intersection of medicinal chemistry and molecular pharmacology. Its multifaceted biological activities and synthetic versatility make it a valuable scaffold for future drug discovery efforts, particularly in the areas of inflammation and oxidative stress-related pathologies.

• 1261895-51-5(3-Fluoro-5-(4-fluoro-3-methoxyphenyl)phenol)
• 1261896-72-3(4-(3-Fluorophenyl)-2-methoxyphenol)
• 1261898-75-2(5-(3,5-Difluorophenyl)-2-methoxyphenol)
• 1261903-84-7(3'-Fluoro-4',5-dimethoxy[1,1'-biphenyl]-3-ol)
• 1262002-53-8(2-fluoro-5-(3-fluoro-4-methoxyphenyl)phenol)
• 1261935-92-5(2-fluoro-4-(4-fluoro-3-methoxyphenyl)phenol)
• 1261895-45-7(2-fluoro-4-(3-methoxyphenyl)phenol)
• 1261919-60-1(5-(3-Fluoro-5-hydroxyphenyl)-2-methoxyphenol)
• 1261896-11-0(3-(3-Fluoro-4-methoxyphenyl)phenol)
• 1261890-90-7(5-(3,4-Dimethoxyphenyl)-2-fluorophenol)